Cite
HARVARD Citation
Jung, K. et al. (n.d.). 2318 Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer. European journal of cancer. pp. S438-S439. [Online].